Skip to main content

Bilateral Hearing Loss

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Oticon
OticonDenmark - Smørum
2 programs
Fitting of Ponto 3 SuperPowerN/A1 trial
Fitting of Ponto 4N/A1 trial
Active Trials
NCT04006132Completed26Est. Jan 2020
NCT04242940Terminated14Est. May 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OticonFitting of Ponto 4
OticonFitting of Ponto 3 SuperPower

Clinical Trials (2)

Total enrollment: 40 patients across 2 trials

NCT04242940OticonFitting of Ponto 4

Assessing Listening Effort at Different Signal-to-noise Ratios in Bone-anchored Users

Start: Feb 2020Est. completion: May 202214 patients
N/ATerminated
NCT04006132OticonFitting of Ponto 3 SuperPower

Evaluation of the Benefits of Bilateral Fitting in BAHS Users

Start: Jul 2019Est. completion: Jan 202026 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.